Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recipient-based approach to tailoring immunosuppression in liver transplantation.

Transplantation proceedings - 1 Jun 2010

Kemmer N, Neff G

Abstract excerpt

Improvements in the field of transplant immunosuppression (IS) have led to significant advances in long-term survival of liver transplant recipients. Despite this progress, survival rates vary depending on recipient, donor and/or perioperative factors. Tailoring IS based on recipient factors is of growing interest among health care providers involved in the care of organ transplant recipients. To date there is no...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholestasis
Share to Cytochrome P-450 CYP3A
Share to Immunosuppression Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunosuppressive Agents

Share to Liver Diseases

Share to Liver Transplantation

Share to Patients

Share to Physician-Patient Relations

Source

Identifiers

PMID: 20620512
DOI: 10.1016/j.transproceed.2010.02.076

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recipient-based approach to tailoring immunosuppression in liver transplantation.PMID 20620512Read ↗

Significance of Ethnic Factors in Immunosuppressive Therapy Management After Organ Transplantation.Semantic proximity Read ↗

Individualization of immunosuppression: concepts and rationale.Semantic proximity Read ↗

Role of Pharmacogenetics of Immunosuppressive Drugs in Organ TransplantationSemantic proximity Read ↗

New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs.Semantic proximity Read ↗

Trends in Precision Medicine and Pharmacogenetics as an Adjuvant in Establishing a Correct Immunosuppressive Therapy for Kidney Transplant: An Up-to-Date Historical OverviewSemantic proximity Read ↗

Understanding and Preventing Adverse Effects of Tacrolimus Metabolization in Transplant Patients.Semantic proximity Read ↗

Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions.Semantic proximity Read ↗

Recent advances in precision medicine for individualized immunosuppression.Semantic proximity Read ↗

Pharmacogenetics in Solid Organ Transplantation: Genes Involved in Mechanism of Action and Pharmacokinetics of Immunosuppressive DrugsSemantic proximity Read ↗

Pharmacokinetics of immunosuppressants: a perspective on ethnic differencesSemantic proximity Read ↗

Effect of Wuzhi preparations on tacrolimus in CYP3A5 expressers during the early period after transplantation: A real-life experience from heart transplant recipients.Semantic proximity Read ↗

Consideration of the ethnic prevalence of genotypes in the clinical use of tacrolimus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.